Cargando…
ACE2, a drug target for COVID-19 treatment?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192920/ https://www.ncbi.nlm.nih.gov/pubmed/35699908 http://dx.doi.org/10.1007/s11845-022-03055-1 |
| _version_ | 1784726333087023104 |
|---|---|
| author | Liu, Yang Huang, Huilian |
| author_facet | Liu, Yang Huang, Huilian |
| author_sort | Liu, Yang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9192920 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91929202022-06-17 ACE2, a drug target for COVID-19 treatment? Liu, Yang Huang, Huilian Ir J Med Sci Letter to the Editor Springer International Publishing 2022-06-14 2023 /pmc/articles/PMC9192920/ /pubmed/35699908 http://dx.doi.org/10.1007/s11845-022-03055-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Liu, Yang Huang, Huilian ACE2, a drug target for COVID-19 treatment? |
| title | ACE2, a drug target for COVID-19 treatment? |
| title_full | ACE2, a drug target for COVID-19 treatment? |
| title_fullStr | ACE2, a drug target for COVID-19 treatment? |
| title_full_unstemmed | ACE2, a drug target for COVID-19 treatment? |
| title_short | ACE2, a drug target for COVID-19 treatment? |
| title_sort | ace2, a drug target for covid-19 treatment? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192920/ https://www.ncbi.nlm.nih.gov/pubmed/35699908 http://dx.doi.org/10.1007/s11845-022-03055-1 |
| work_keys_str_mv | AT liuyang ace2adrugtargetforcovid19treatment AT huanghuilian ace2adrugtargetforcovid19treatment |